Zimmer Biomet Holdings Inc (NYSE: ZBH) is -7.95% lower on its value in year-to-date trading and has touched a low of $101.47 and a high of $133.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZBH stock was last observed hovering at around $110.64 in the last trading session, with the day’s gains setting it 1.38%.
Currently trading at $112.02, the stock is 2.08% and 4.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 1.25% at the moment leaves the stock -1.87% off its SMA200. ZBH registered -0.95% loss for a year compared to 6-month loss of -2.11%. The firm has a 50-day simple moving average (SMA 50) of $107.06 and a 200-day simple moving average (SMA200) of $114.1571.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 7.84% gain in the last 1 month and extending the period to 3 months gives it a -2.31%, and is 2.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.66% over the week and 2.01% over the month.
Zimmer Biomet Holdings Inc (ZBH) has around 18000 employees, a market worth around $22.58B and $7.60B in sales. Current P/E ratio is 21.34 and Fwd P/E is 13.04. Profit margin for the company is 14.27%. Distance from 52-week low is 10.40% and -16.34% from its 52-week high. The company has generated returns on investments over the last 12 months (6.33%).
Zimmer Biomet Holdings Inc quarterly earnings per share for the current quarter are estimated at 2.3 with sales reaching $2.02B over the same period.The EPS is expected to grow by 5.85% this year, but quarterly earnings will post 3.72% year-over-year. Quarterly sales are estimated to grow 3.90% in year-over-year returns.
1366.0 institutions hold shares in Zimmer Biomet Holdings Inc (ZBH), with institutional investors hold 93.55% of the company’s shares. The shares outstanding are 205.60M, and float is at 198.80M with Short Float at 3.45%. Institutions hold 93.42% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 23.4 million shares valued at $2.54 billion. The investor’s holdings represent 11.4041 of the ZBH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.84 million shares valued at $1.83 billion to account for 8.205 of the shares outstanding. The other top investors are DODGE & COX which holds 16.75 million shares representing 8.1606 and valued at over $1.82 billion, while PRICE T ROWE ASSOCIATES INC /MD/ holds 6.0942 of the shares totaling 12.51 million with a market value of $1.36 billion.
Zimmer Biomet Holdings Inc (ZBH) Insider Activity
The most recent transaction is an insider sale by Yi Sang, the company’s Group President, Asia Pacific. SEC filings show that Yi Sang sold 12,857 shares of the company’s common stock on May 31 ’24 at a price of $114.69 per share for a total of $1.47 million. Following the sale, the insider now owns 5322.0 shares.
Zimmer Biomet Holdings Inc disclosed in a document filed with the SEC on Mar 07 ’24 that Yi Sang (Group President, Asia Pacific) sold a total of 1,705 shares of the company’s common stock. The trade occurred on Mar 07 ’24 and was made at $126.86 per share for $0.22 million. Following the transaction, the insider now directly holds 18179.0 shares of the ZBH stock.
Still, SEC filings show that on Feb 22 ’24, Phipps Chad F (Sr. VP/Gen Counsel/Secretary) disposed off 26,156 shares at an average price of $128.62 for $3.36 million. The insider now directly holds 44,145 shares of Zimmer Biomet Holdings Inc (ZBH).
